Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07197840) titled 'The CHALLENGER Registry' on Sept. 26.

Study Type: Observational [Patient Registry]

Primary Sponsor: Icahn School of Medicine at Mount Sinai

Condition: Chronic Subdural Hemorrhage (cSDH)

Intervention: Device: Numen SILK coil embolization system

Recruitment Status: Not recruiting

Date of First Enrollment: March 1, 2026

Target Sample Size: 100

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07197840

Published by HT Digital Content Services with permission from Health Daily Digest....